Mark C. Genovese - Concepedia

Author

Mark C. Genovese

Also Known As

A. Finckh, A. Taylor, E. C. Keystone, Genovese, Mark, Genovese, Mark C., I. Delaet, K. Patra, Kevin Deane, M C Genovese, M Genovese

438

Publications

32.7K

Citations

H-Index

Concepts

All Affiliations

Stanford University Stanford Medicine Palo Alto University Eli Lilly (United States)Metroplex Clinical Research Center

About

Mark C. Genovese is an author at Stanford University specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	25	3.9K
2	Allergy	2	2	58
3	Engineering	1	1	676
4	Health Sciences	1	1	21
5	Public Health	1	1	277

Mark C. Genovese

197

Publications

28.7K

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Joan M. Bathon, Richard W. Martin, Roy Fleischmann, New England Journal of Medicine	2000	1.8K
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks Stanley Cohen, Paul Emery, Maria Greenwald, Arthritis & Rheumatism	2006	1.6K
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition Mark C. Genovese, Jean‐Claude Becker, Michael Schiff, New England Journal of Medicine	2005	1.2K
Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study Mark C. Genovese, James D. McKay, Eduardo Mysler, Arthritis & Rheumatism	2008	853
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes Mark C. Genovese, Joan M. Bathon, Richard W. Martin, Arthritis & Rheumatism	2002	731
Autoantigen microarrays for multiplex characterization of autoantibody responses William H. Robinson, Carla DiGennaro, Wolfgang Hueber, Nature Medicine Autoantigen MicroarraysFunctional GenomicsEngineeringMedicineComputational Biology	2002	676
Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment Eric J. Kunkel, James J. Campbell, Guttorm Haraldsen, The Journal of Experimental Medicine	2000	623
Baricitinib in Patients with Refractory Rheumatoid Arthritis Mark C. Genovese, Joel Kremer, Omid Zamani, New England Journal of Medicine	2016	598
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study Edward Keystone, Mark C. Genovese, Lars Klareskog, Annals of the Rheumatic Diseases	2008	527
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate Mark C. Genovese, Stanley Cohen, Larry W. Moreland, Arthritis & Rheumatism	2004	518

Page 1